Surfome analysis as a fast track to vaccine discovery: Identification of a novel protective antigen for group B Streptococcus hypervirulent strain COH1

Molecular and Cellular Proteomics

Volumn 8, Issue 7, 2009, Pages 1728-1737

  Doro, Francesco ^a   Liberatori, Sabrina ^a   Rodríguez Ortega, Manuel J ^b   Rinaudo, Cira D ^a   Rosini, Roberto ^a   Mora, Marirosa ^a   Scarselli, Maria ^a   Altindis, Emrah ^a   D'Aurizio, Romina ^a   Stella, Maria ^a   Margarit, Immaculada ^a   Maione, Domenico ^a   Telford, John L ^a   Norais, Nathalie ^a   Grandi, Guido ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SAN 1485 ANTIGEN; SERINE; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL WALL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GRAM POSITIVE BACTERIUM; GROUP B STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCUS COH1; IMMUNIZATION; MASS SPECTROMETRY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; RELIABILITY; STREPTOCOCCUS AGALACTIAE; VACCINE PRODUCTION; WHOLE CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; FEMALE; MOLECULAR SEQUENCE DATA; PROTEOME; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VACCINES, SYNTHETIC;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS SP. 'GROUP B';

EID: 71049163771     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M800486-MCP200     Document Type: Article

References (52)

1. Anonymous (2008) The value of vaccines. Nat. Rev. Microbiol. 6, 2
2. Rappuoli, R. (2000) Reverse vaccinology. Curr. Opin. Microbiol. 3, 445-450
3. Grandi, G. (2006) Genomics and proteomics in reverse vaccines. Methods Biochem. Anal. 49, 379-393
4. Johri, A. K., Paoletti, L. C., Glaser, P., Dua, M., Sharma, P. K., Grandi, G., and Rappuoli, R. (2006) Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4, 932-942
5. Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., Galeotti, C. L., Luzzi, E., Manetti, R., Marchetti, E., Mora, M., Nuti, S., Ratti, G., Santini, L., Savino, S., Scarselli, M., Storni, E., Zuo, P., Broeker, M., Hundt, E., Knapp, B., Blair, E., Mason, T., Tettelin, H., Hood, D. W., Jeffries, A. C., Saunders, N. J., Granoff, D. M., Venter, J. C., Moxon, E. R., Grandi, G., and Rappuoli, R. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816-1820
6. Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., Rosini, R., D'Agostino, N., Miorin, L., Buccato, S., Mariani, M., Galli, G., Nogarotto, R., Nardi Dei, V., Vegni, F., Fraser, C., Mancuso, G., Teti, G., Madoff, L. C., Paoletti, L. C., Rappuoli, R., Kasper, D. L., Telford, J. L., and Grandi, G. (2005) Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309, 148-150 (Pubitemid 40934997)
7. Rodríguez-Ortega, M. J., Norais, N., Bensi, G., Liberatori, S., Capo, S., Mora, M., Scarselli, M., Dora, F., Ferrari, G., Garaguso, I., Maggi, T., Neumann, A., Covre, A., Telford, J. L., and Grandi, G. (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat. Biotechnol. 24, 191-197
8. Fernandez-Espla, M. D., Garault, P., Monnet, V., and Rul, F. (2000) Streptococcus thermophilus cell wall-anchored proteinase: release, purification, and biochemical and genetic characterization. Appl. Environ. Microbiol. 66, 4772-4778
9. Harris, T. O., Shelver, D. W., Bohnsack, J. F., and Rubens, C. E. (2003) A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J. Clin. Investig. 111, 61-70
10. Lei, B., Mackie, S., Lukomski, S., and Musser, J. M. (2000) Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect. Immun. 68, 6807-6818
11. Schuchat, A., and Wenger, J. D. (1994) Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol. Rev. 16, 374-402
12. Tyrrell, G. J., Senzilet, L. D., Spika, J. S., Kertesz, D. A., Alagaratnam, M., Lovgren, M., and Talbot, J. A. (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study - 1996. Sentinel Health Unit Surveillance System Site Coordinators. J. Infect. Dis. 182, 168-173
13. Harrison, L. H., Elliott, J. A., Dwyer, D. M., Libonati, J. P., Fernen, P., Billmann, L., and Schuchat, A. (1998) Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J. Infect. Dis. 177, 998-1002
14. Hansen, S. M., Uldbjerg, N., Kilian, M., and Sørensen, U. B. (2004) Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J. Clin. Microbiol. 42, 83-89
15. Dermer, P., Lee, C., Eggert, J., and Few, B. (2004) A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States. J. Pediatr. Nurs. 19, 357-363
16. Edwards, M. S., and Baker, C. J. (2005) Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41, 839-847
17. Cheng, Q., Carlson, B., Pillai, S., Eby, R., Edwards, L., Olmsted, S. B., and Cleary, P. (2001) Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect. Immun. 69, 2302-2308
18. Cheng, Q., Debol, S., Lam, H., Eby, R., Edwards, L., Matsuka, Y., Olmsted, S. B., and Cleary, P. P. (2002) Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice. Infect. Immun. 70, 6409-6415
19. Brodeur, B. R., Boyer, M., Charlebois, I., Hamel, J., Couture, F., Rioux, C. R., and Martin, D. (2000) Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect. Immun. 68, 5610-5618
20. Martin, D., Rioux, S., Gagnon, E., Boyer, M., Hamel, J., Charland, N., and Brodeur, B. R. (2002) Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect. Immun. 70, 4897-4901
21. Seepersaud, R., Hanniffy, S. B., Mayne, P., Sizer, P., Le Page, R., and Wells, J. M. (2005) Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity. Infect. Immun. 73, 1671-1683
22. Larsson, C., Stålhammar-Carlemalm, M., and Lindahl, G. (1996) Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha. Infect. Immun. 64, 3518-3523
23. Larsson, C., Stålhammar-Cariemalm, M., and Lindahl, G. (1999) Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine. Vaccine 17, 454-458 (Pubitemid 29064002)
24. Stålhammar-Carlemalm, M., Stenberg, L., and Lindahl, G. (1993) Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177, 1593-1603
25. Lauer, P., Rinaudo, C. D., Soriani, M., Margarit, I., Maione, D., Rosini, R., Taddei, A. R., Mora, M., Rappuoli, R., Grandi, G., and Telford, J. L. (2005) Genome analysis reveals pili in Group B Streptococcus. Science 309, 105 (Pubitemid 40934983)
26. Rosini, R., Rinaudo, C. D., Soriani, M., Lauer, P., Mora, M., Maione, D., Taddei, A., Santi, I., Ghezzo, C., Brettoni, C., Buccato, S., Margarit, I., Grandi, G., and Telford, J. L. (2006) Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae. Mol. Microbiol. 61, 126-141
27. Gardy, J. L., Laird, M. R., Chen, F., Rey, S., Walsh, C. J., Ester, M., and Brinkman, F. S. (2005) PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21, 617-623 (Pubitemid 40424787)
28. Taylor, P. D., Toseland, C. P., Attwood, T. K., and Flower, D. R. (2006) LIPPRED: a web server for accurate prediction of lipoprotein signal sequences and cleavage sites. Bioinformation 1, 176-179
29. Montigiani, S., Falugi, F., Scarselli, M., Finco, O., Petracca, R., Galli, G., Mariani, M., Manetti, R., Agnusdei, M., Cevenini, R., Donati, M., Nogarotto, R., Norais, N., Garaguso, I., Nuti, S., Saletti, G., Rosa, D., Ratti, G., and Grandi, G. (2002) Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect. Immun. 70, 368-379
30. Rodewald, A. K., Onderdonk, A. B., Warren, H. B., and Kasper, D. L. (1992) Neonatal mouse model of group B streptococcal infection. J. Infect. Dis. 166, 635-639
31. Marques, M. A., Chitale, S., Brennan, P. J., and Pessolani, M. C. (1998) Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect. Immun. 66, 2625-2631
32. Dallo, S. F., Kannan, T. R., Blaylock, M. W., and Baseman, J. B. (2002) Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol. Microbiol. 46, 1041-1051
33. Spence, J. M., and Clark, V. L. (2000) Role of ribosomal protein L12 in gonococcal invasion of Hec1B cells. Infect. Immun. 68, 5002-5010
34. Kurar, E., and Splitter, G. A. (1997) Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15, 1851-1857 (Pubitemid 27504679)
35. Padmalayam, I., Anderson, B., Kron, M., Kelly, T., and Baumstark, B. (1997) The 75-kilodalton antigen of Bartonella bacilliformis is a structural homolog of the cell division protein FtsZ. J. Bacteriol. 179, 4545-4552 (Pubitemid 27299071)
36. Grandi, G. (2001) Antibacterial vaccine design using genomics and proteomics. Trends Botechnol. 19, 181-188
37. Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Anco, B., Savino, S., Santini, L., Brunelli, B., Bambini, S., Biolchi, A., Capecchi, B., Cartocci, E., Ciucchi, L., Di Marcello, F., Ferlicca, F., Galli, B., Luzzi, E., Masignani, V., Serruto, D., Veggi, D., Contomi, M., Morandi, M., Bartalesi, A., Cinotti, V., Mannucci, D., Titta, F., Ovidi, E., Welsch, J. A., Granoff, D., Rappuoli, R., and Pizza, M. (2006) A universal vaccine for serogroup B meningococcus. Proc. Natl. Acad. Sci. U.S.A. 103, 10834-10839
38. Stranger-Jones, Y. K., Bae, T., and Schneewind, O. (2006) Vaccine assembly from surface proteins of Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 103, 16942-16947
39. Lancefield, R. C., and Dole, V. P. (1946) The properties of T antigens extracted from group A hemolytic streptococci. J. Exp. Med. 84, 449-471
40. Kang, H. J., Coulibaly, F., Clow, F., Proft, T., and Baker, E. N. (2007) Stabilizing isopeptide bonds revealed in gram-positive bacterial pilus structure. Science 318, 1625-1628 (Pubitemid 350233661)
41. Tettelin, H., Masignani, V., Cieslewicz, M. J., Donati, C., Medini, D., Ward, N. L., Angiuoli, S. V., Crabtree, J., Jones, A. L., Durkin, A. S., Deboy, R. T., Davidsen, T. M., Mora, M., Scarselli, M., Margarit y Ros, I., Peterson, J. D., Hauser, C. R., Sundaram, J. P., Nelson, W. C., Madupu, R., Brinkac, L. M., Dodson, R. J., Rosovitz, M. J., Sullivan, S. A., Daugherty, S. C., Haft, D. H., Selengut, J., Gwinn, M. L., Zhou, L., Zafar, N., Khouri, H., Radune, D., Dimitrov, G., Watkins, K., O'Connor, K. J., Smith, S., Utterback, T. R., White, O., Rubens, C. E., Grandi, G., Madoff, L. C., Kasper, D. L., Telford, J. L., Wessels, M. R., Rappuoli, R., and Fraser, C. M. (2005) Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. U.S.A. 102, 13950-13955
42. Seifert, K. N., Adderson, E. E., Whiting, A. A., Bohnsack, J. F., Crowley, P. J., and Brady, L. J. (2006) A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 152, 1029-1040
43. Jones, N., Bohnsack, J. F., Takahashi, S., Oliver, K. A., Chan, M. S., Kunst, F., Glaser, P., Rusniok, C., Crook, D. W., Harding, R. M., Bisharat, N., and Spratt, B. G. (2003) Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41, 2530-2536
44. Luan, S. L., Granlund, M., Sellin, M., Lagergård, T., Spratt, B. G., and Norgren, M. (2005) Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43, 3727-3733
45. Ferrari, G., Garaguso, I., Adu-Bobie, J., Doro, F., Taddei, A. R., Biolchi, A., Brunelli, B., Giuliani, M. M., Pizza, M., Norais, N., and Grandi, G. (2006) Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6, 1856-1866
46. Berlanda Scorza, F., Doro, F., Rodríguez-Ortega, M. J., Stella, M., Liberatori, S., Taddei, A. R., Serino, L., Gomes Moriel, D., Nesta, B., Fontana, M. R., Spagnuolo, A., Pizza, M., Norais, N., and Grandi, G. (2008) Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol. Cell. Proteomics 7, 473-485
47. Bernadac, A., Gavioli, M., Lazzaroni, J. C., Raina, S., and Lloubès, R. (1998) Escherichia coli tol-pal mutants form outer membrane vesicles. J. Bacteriol. 180, 4872-4878 (Pubitemid 28429375)
48. Yem, D. W., and Wu, H. C. (1978) Physiological characterization of an Escherichia coli mutant altered in the structure of murein lipoprotein. J. Bacteriol. 133, 1419-1426 (Pubitemid 8297002)
49. Masignani, V., Rappuoli, R., and Pizza, M. (2002) Reverse vaccinology: a genome-based approach for vaccine development. Expert Opin. Biol. Ther. 2, 895-905
50. Mora, M., Veggi, D., Santini, L., Pizza, M., and Rappuoli, R. (2003) Reverse vaccinology. Drug. Discov. Today 8, 459-464
51. Etz, H., Minh, D. B., Henics, T., Dryla, A., Winkler, B., Triska, C., Boyd, A. P., Söllner, J., Schmidt, W., von Ahsen, U., Buschle, M., Gill, S. R., Kolonay, J., Khalak, H., Fraser, C. M., von Gabain, A., Nagy, E., an Meinke, A. (2002) Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 99, 6573-6578
52. Henics, T., Winkler, B., Pfeifer, U., Gill, S. R., Buschle, M., von Gabain, A., and Meinke, A. L. (2003) Small-fragment genomic libraries for the display of putative epitopes from clinically significant pathogens. BioTechniques 35, 196-202, 204, 206 passim